drugset / Trial / NCT00630838

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)

NCT00630838

Phase 2 Completed 62 enrolled University of Michigan
RandomizedParallel-groupTriple-blindPrevention

Summary

Prospective, randomized, controlled trial to test if post-operative administration of probiotics in HD patients will lead to a reduction in the occurrence of HAEC.

Timeline

Start
2006-09
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject VSL#3 Other / unclassified 0.5 g Oral
Subject VSL#3 Other / unclassified 1 g Oral

Indications